AR226-2578 Lfiiirf) Waller DocumenI 10 of 16 ASB017491 EID477528 I I I I I I I I I III ^ ,^1\ - ) J '^SHiSy I I I I I I I I OHIO RIVER WATER SAMPLING PROPOSAL FOR THE WASHINGTON WORKS FACILITY AND THE LETART LANDFILL Date: February 2002 Project No.: D6WW7423 CORPORATE REMEDIATION GROUP An Alliance between DuPontand URS Diamond Barley Mill Plaza, Building 27 Wilmlngton, Delaware 19805 AJ3H017492 EID477529 Jp ,, ~1 1 1 1 Bill) ,i(;"aB^ -\ J - " 1 1 1 1 1 1 Ohio River Water Sampling Proposal Table Of Contents TABLE OF CONTENTS 1.0 Introduction.--.............,,,........,,........,.,..,...,.........,...,,....................,...,... 1 2.0 River Water Sampling Approach Near The Washington Works Facility................ .,3 3.0 River Water Sampling Near the Letart Landfill.................................................. 5 Table 1 Figure 1A Figure 1B Figure 2 TABLES Proposed River Water SamplingPlan DuPont Washington Works Facility and Letart Landfill FIGURES Proposed Ohio River Water Sampling Locations - Upstream, DuPont Washington Works Facility Proposed Ohio River Water Sampling Locations Downstream, DuPont Washington Works Facility Proposed Otuo River Water Sampling Locations, Letart Landfill Site revZrtwr.dOC F8b. 27,02 ( Wilrnlngton, DE ASH0174&3 EID477530 I Ohio RIvar Water Sampling Proposal Introduction ] 1.0 INTRODUCTION I I I I 1I A multi-media Consent Order (Order No.

AR226-2588 rAndrBwirRartteh" ---- ' "'^n^02?

AR226-2642 31 AR226-2642 Shimizu C8 Modeling Results -10/4/04 Scenario PlanB-1 (w/oDBS) Plan B-2(w/o DBS) Plan B-3, DBS @95% Plan B-3, DBS @96% Plan B-3, DBS @98% Plan B-4, DBS @95% Plan B-4, DBS @96% Plan B-4, DBS @98% Maximum Annual Average (all concentrations in ug/m3) 1997 0.836 0.637 0.283 0.234 0.099 0.191 0.161 0.076 1998 0.992 0.762 0.338 0.279 0.118 0.233 0.196 0.092 1999 0.824 0.622 0.276 0.228 0.097 0.184 0.154 0.074 Note: All maximum predicted annual average concentrations occur on the plant fenceline.

AR226-2659 (!

Customer Opinion Letter Response Opinion for PFAS Proposal (1) We would like to express our greetings to the five countries proposing the ECHA and PFAS control draft on behalf of NATOR Lubrication (Shanghai) Co., Ltd.

Study Sponsor: Issue Date: Document Reference No.: ELFATOCHEM 04-Jul-95 95/SAEK/0489/AMP AR226-3021 Bacterial Growth Inhibition Author(s): Coil: H.

AR226-3089 HASKELL LABORATORY FOR TOXICOLOGY AND INDUSTRIAL MEDICINE H-23005: STATIC, ACUTE 48-HOUR SCREENING TEST TO Daphnia magna PURPOSE: This is a rangefinding study designed to provide an estimate of aquatic toxicity using fixed test concentrations and data measurements at predetermined intervals.

| AR 246 - 3229 | a1 | ARARG _ 3427 DuPont-8867 TRADE SECRET Study Title 'H-25170: Bacterial Reverse Mutation Test with an Independent Repeat Assay Authors Valentine O.

ARR26 _ 3251 = --_ --Tr TRADE SECRET ARR26 325] DluPiont11238 Study Title H-25357: Approximate Lethal Dose (ALD) by Skin Absorption in Rabbits Laboratory Project ID: DuPont-11238 AUTHOR: Carol Finlay, B.A

Guidance Document - AGC Chemicals Europe Ltd 1.

Different typs of PTFE-bellows in various lenghts.

Attachment 1 Detailed explanation on essential use of PFAS in printer / copier Printing / copying process and the key functions Sliding function Functions essential for printers and copiers, such as lubrication, water and oil repellency, chemical resistance, and charging-ability for driving and sealing parts (rollers, bearings, gears, separation plates, inkjet heads, sheets, flanges, rings, etc.)

Application Number: E2.9_Fluororesins for medical device applications Fluororesin used: PTFE (CAS No. 9002-84-0) Product overview: Gasket for prefilled syringe (sliding stopper) A fluororesin film is used in a gasket for a prefilled syringe for medical device applications.

AR 226 -- HI?